Overview
- Dr Reddy’s signed a definitive deal to acquire India trademarks and related assets for Progynova and Cyclo‑Progynova from UK-based Mercury Pharma Group for $32.15 million.
- Cochin Shipyard inked a contract worth over Rs 2,000 crore with CMA CGM to design and build six LNG-powered feeder container vessels of about 1,700 TEU each, with deliveries spanning 36 to 64 months.
- Zydus Lifesciences received final USFDA approval for bosentan tablets for oral suspension, 32 mg, for pulmonary arterial hypertension, to be manufactured at its Ahmedabad SEZ facility.
- Hindustan Unilever’s board cleared roughly Rs 2,000 crore of investment over two years to expand manufacturing capacity in premium beauty, wellbeing, and home care categories.
- NCC, along with OB Infrastructure, was debarred by NHAI from participating in its tenders for two years effective February 17, 2026, with companies indicating existing projects remain unaffected.